Zobrazeno 1 - 10
of 175
pro vyhledávání: '"H, Mouriesse"'
Autor:
H. Mouriesse, F. May-Levin, J. C. Delarue, M. Gotteland, E. May, Hélène Sancho-Garnier, Geneviève Contesso
Publikováno v:
European Journal of Cancer. 31:1851-1855
Recently, it was found that, among post menopausal breast cancer patients receiving no adjuvant therapy, the highest oestrogen receptor (ER) levels (ER ++ ) as opposed to the intermediate ER levels (ER + ) indicated a poorer prognosis in terms of rec
Autor:
Evelyne May, F. May-Levin, J. C. Delarue, Geneviève Contesso, Marianne Gotteland, H. Mouriesse
Publikováno v:
Cancer. 74:864-871
Background The response to endocrine therapy is not entirely predictable from the estrogen receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors previously proposed a new prognostic factor, ER.R, which was based o
Autor:
Rodrigo Arriagada, Gerrit DeBoer, R.M. Clark, R. S. Bush, A. Rezvani, Danièle Sarrazin, H. Mouriesse
Publikováno v:
Radiotherapy and Oncology. 27:1-6
This retrospective analysis was conducted on breast cancer patients treated by radiotherapy alone at The Princess Margaret Hospital and at the Institut Gustave-Roussy. These patients had either operable tumors, but were unfit for general anesthesia,
Publikováno v:
Radiation Oncology Investigations. 1:63-70
This retrospective analysis involved 453 breast cancer patients treated by radiotherapy alone at the Princess Margaret Hospital and at the Institut Gustave-Roussy. These patients either had operable tumors, but were unfit for general anesthesia, or h
Autor:
C. Cuvier, F. Fontaine, Danièle Sarrazin, F. May-Levin, Marc Spielmann, Jean-Paul Travagli, Rodrigo Arriagada, T. Le Chevalier, A. Mezlini, P. Oudinot, H. Mouriesse
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:1207-1210
Ninety-nine patients presenting with non-metastatic inflammatory breast cancer were treated with an alternating protocol of radiotherapy and chemotherapy. The alternating schedule consisted of 8 courses of combined chemotherapy, including doxorubicin
Publikováno v:
Tumori. 84(5)
Background An increased risk of cancer and autoimmune diseases associated with gel-filled silicone implants, debated by FDA experts since 1991, has given rise to a profusion of literature on the subject. However, such effects have not been adequately
Publikováno v:
Bulletin du cancer. 84(10)
We have compared different modes of rehabilitation after breast cancer surgery on a population of 257 patients treated at the Institute Gustave-Roussy in 1990 and 1991. The mode of rehabilitation was randomized according to a 2 X 2 design, between ph
Publikováno v:
Annales de chirurgie plastique et esthetique. 42(2)
The authors discuss the immunological and oncological risk of prefilled silicone gel breast implants. A comparative study of 146 patients undergoing breast reconstruction by silicone implant at the Institut Gustave-Roussy and 146 matched controls dem
Autor:
Philippe Terrier, H. Mouriesse, Brigitte Loridon, F. May-Levin, J. C. Delarue, Marianne Gotteland
Publikováno v:
Acta oncologica (Stockholm, Sweden). 35(1)
A rabbit-specific polyclonal antibody was obtained raised to a synthetic peptide corresponding to the 1238-1255 C-terminal predicted sequence of the c-erbB-2 protein. This antibody was used in an immunohistochemical procedure to detect the c-erbB-2 p
Autor:
Marc Spielmann, François Thomas, Thierry Le Chevalier, Thomas Tursz, F. Fontaine, Rodrigo Arriagada, H. Mouriesse
Publikováno v:
Cancer. 76(11)
Background. Patients with inflammatory breast cancer have a high risk of developing a local recurrence and/or distant metastases. Treatment with combined chemotherapy and locoregional radiotherapy contributes to a decrease in both risks. This study p